]>
IRCT20170422033566N2 IRCT 2018-06-25 Gorgan University of Medical Sciences Survey of effect of topical herbal medicine (neurohelp) on the treatment of diabetic neuropathy Survey of effect of topical herbal medicine (neurohelp) on the treatment of diabetic neuropathy: a Randomized Clinical Trial 2018-04-19 anticipated 70 Complete https://irct.ir/trial/31005 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Block Randomization. 3 Diabetic neuropathy. Intervention 1: Intervention group: Standard treatment (Gabapentin and Vitamins) + liquid synthetic neurohelp. Intervention 2: Control group: Standard treatment (Gabapentin and Vitamins) + Placebo. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is No more information.
public Ourman Nezami Narjabad
Hirkan Ave
Gorgan Iran (Islamic Republic of) 4934174515 +98 17 3243 0310 f.mehravar@goums.ac.ir Gorgan University of Medical Sciences scientific Maryam Zahedi
Sayad Shirazi Blvd
Gorgan Iran (Islamic Republic of) 4934174515 +98 17 3242 1653 drmaryam.zahedi@yahoo.com Gorgan University of Medical Sciences Iran (Islamic Republic of) Patients with type 2 diabetes with uncontrolled blood sugar diabetic peripheral neuropathy aged between 30-70 years 30 years 70 years Both Drug and alcohol users Other reasons for the development of neuropathy, liver and kidney failure Disruption of sodium, potassium, calcium electrolytes Pregnancy or breastfeeding Wound or foot infections Lack of full awareness of patient Treatment - Drugs Treatment - Drugs Intervention group: Standard treatment (Gabapentin and Vitamins) + liquid synthetic neurohelp. Control group: Standard treatment (Gabapentin and Vitamins) + Placebo Pain. Timepoint: At the beginning of the study, 2 weeks after the start of the study, 2 months and 3 months after the start of the study. Method of measurement: Visual Analogue Scale (VAS). FBS. Timepoint: At the beginning of the study, 2 weeks after the start of the study, 2 months and 3 months after the start of the study. Method of measurement: by glucose oxidase method. 2HPR. Timepoint: At the beginning of the study, 2 weeks after the start of the study, 2 months and 3 months after the start of the study. Method of measurement: by glucose oxidase method. B/S4PM. Timepoint: At the beginning of the study, 2 weeks after the start of the study, 2 months and 3 months after the start of the study. Method of measurement: by glucose oxidase method. Tingling. Timepoint: At the beginning of the study, 2 weeks after the start of the study, 2 months and 3 months after the start of the study. Method of measurement: Visual Analogue Scale (VAS). Numb. Timepoint: At the beginning of the study, 2 weeks after the start of the study, 2 months and 3 months after the start of the study. Method of measurement: Visual Analogue Scale (VAS). HbA1C. Timepoint: Start the study, three months after the intervention. Method of measurement: Blood glucose testing will be done using the Pars Test Kit and the HbA1C Assay with Diaz Kit with the diory 1200 automatic device. Gorgan University of Medical Sciences Approved 2018-04-14 Ethics committee of Golestan University of Medical Sciences هیرکان gorgan Golestan Iran (Islamic Republic of)